CSIMarket
 
Flexion Therapeutics Inc   (NASDAQ: FLXN)
 

Flexion Therapeutics Inc's Suppliers Performance

FLXN's Supply Chain




 
FLXN Costs vs Sales of Suppliers Growth Flexion Therapeutics Inc's cost of sales deteriorated by -27.35 % year on year, relative to one quarter ago cost of sales fell by -25.15 % in Q3.

• More on FLXN Suppliers



Flexion Therapeutics Inc's cost of sales deteriorated by -27.35 % year on year, compare to one quarter ago cost of sales fell by -25.15 % in Q3.

• More on FLXN Suppliers




Flexion Therapeutics Inc's Comment on Supply Chain









FLXN's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Flexion Therapeutics Inc 1,262.91 100.40 -100.72 215
SUBTOTAL 0.00 0.00 0.00 -


Sources: Flexion Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Flexion Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.